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Abstract. 
 
The functional characteristics of the tight
junction protein ZO-3 were explored through exoge-
nous expression of mutant protein constructs in MDCK
cells. Expression of the amino-terminal, PSD95/dlg/
ZO-1 domain-containing half of the molecule (NZO-3)
delayed the assembly of both tight and adherens junc-
tions induced by calcium switch treatment or brief ex-
posure to the actin-disrupting drug cytochalasin D.
Junction formation was monitored by transepithelial
resistance measurements and localization of junction-
speciﬁc proteins by immunoﬂuorescence. The tight
junction components ZO-1, ZO-2, endogenous ZO-3,
and occludin were mislocalized during the early stages
of tight junction assembly. Similarly, the adherens junc-
 
tion proteins E-cadherin and 
 
b
 
-catenin were also de-
layed in their recruitment to the cell membrane, and
NZO-3 expression had striking effects on actin cyto-
skeleton dynamics. NZO-3 expression did not alter ex-
pression levels of ZO-1, ZO-2, endogenous ZO-3, oc-
cludin, or E-cadherin; however, the amount of Triton
X-100–soluble, signaling-active 
 
b
 
-catenin was increased
in NZO-3–expressing cells during junction assembly. In
vitro binding experiments showed that ZO-1 and actin
preferentially bind to NZO-3, whereas both NZO-3
and the carboxy-terminal half of the molecule (CZO-3)
contain binding sites for occludin and cingulin. We hy-
pothesize that NZO-3 exerts its dominant-negative ef-
fects via a mechanism involving the actin cytoskeleton,
ZO-1, and/or 
 
b
 
-catenin.
Key words: zonula occludens-3 protein • tight junc-
tion • cadherins • actin cytoskeleton • 
 
b
 
-catenin
 
Introduction
 
Regulated transport of substances across a polarized epi-
thelial cell sheet occurs via two distinct routes: the trans-
cellular pathway, where substances are vectorially trans-
ported through the cytoplasm (transcytosis); and the
paracellular pathway, where molecules selectively pass
through the spaces between adjoining cells. The tight junc-
tion (TJ)
 
1
 
 is the structural element that forms a physical
barrier to the movement of molecules through the paracel-
lular space (gate function) and also maintains the polariza-
tion of apical and basolateral membrane domains by re-
stricting the movement of lipids and membrane proteins
within the plane of the membrane (fence function).
Since the identification and characterization of the
membrane-associated guanylate kinase (MAGUK) pro-
tein ZO-1 (Stevenson et al., 1986), other TJ-associated
proteins have been discovered, now totaling at least 15 pe-
ripheral and 3 integral membrane proteins including the
multiple members of the claudin family (Morita et al.,
1999). However, our understanding of the functions of
these proteins, particularly those peripherally associated
with the TJ membrane, is minimal. As a first step towards
this understanding, determining how junctional proteins
interact will help decipher TJ physiology at the molecular
level. Two additional MAGUK family proteins, ZO-2 (Je-
 
saitis and Goodenough, 1994; Beatch et al., 1996) and ZO-3
(Haskins et al., 1998) have been shown to interact directly
with ZO-1 (Haskins et al., 1998; Wittchen et al., 1999) but
not with each other (Haskins et al., 1998). ZO-1/ZO-2 and
ZO-1/ZO-3 likely exist as two distinct heterodimers in
vivo and not as a trimeric complex as previously thought
(Wittchen et al., 1999). All three ZO proteins interact di-
rectly with the carboxy-terminal 150 amino acids of occlu-
din (Furuse et al., 1994; Haskins et al., 1998; Wittchen et
al., 1999) and claudin 1–8 (Itoh et al., 1999a). ZO-1, ZO-2,
and ZO-3 also bind actin filaments (Itoh et al., 1997; Fan-
ning et al., 1998; Wittchen et al., 1999), providing multiple
linkage sites to the actin cytoskeleton. Furthermore, ZO-1,
ZO-2, and ZO-3 all interact with another TJ plaque pro-
tein, cingulin (Cordenonsi et al., 1999), and ZO-1 can asso-
ciate with the Ras-effector molecule AF-6 (Yamamoto et
al., 1997) and the integral membrane protein JAM (Baz-
zoni et al., 2000).
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ZO-1, ZO-2, and ZO-3 contain a conserved series of
well-known protein–protein interaction motifs. All three
proteins have three amino-terminal PSD95/dlg/ZO-1
(PDZ) domains, followed by a Src homology 3 (SH3) do-
main and a guanylate kinase (GUK) domain. The car-
boxy-terminal portion of ZO-1 and ZO-2 consists of a pro-
line-rich region; however, in ZO-3 this proline-rich region
is located in the amino-terminal half of the protein be-
tween PDZ2 and PDZ3. The specific domains responsible
for the various binding interactions of ZO-1, ZO-2, and
ZO-3 have, in part been defined. ZO-1 and ZO-2 form a
complex through reciprocal interactions between their
PDZ2 domains (Fanning et al., 1998; Itoh et al., 1999b),
and ZO-3 likely interacts with ZO-1 in the same manner
(Itoh et al., 1999a). ZO-1 interaction with occludin likely
occurs through the GUK domain, and actin binding via a
region that encompasses the proline-rich domain of ZO-1
(Fanning et al., 1998). ZO-1, ZO-2, and ZO-3 binding to
the carboxy-terminal YV sequence of claudin 1–8 requires
the first PDZ domain of each protein (Itoh et al., 1999a).
Finally, the amino-terminal region of ZO-1 and ZO-2
binds to 
 
a
 
-catenin, and ZO-1 and ZO-2 are components of
the adherens junction (AJ) in certain nonepithelial cells
(Itoh et al., 1997, 1999b). No further information on indi-
vidual domain binding characteristics or overall protein
function(s) is available for ZO-3.
One current model for TJ assembly involves the coordi-
nate assembly of the AJ and TJ. This model proposes that
the first step in de novo junction formation involves E-cad-
herin–mediated cell adhesion (Gumbiner et al., 1988), fol-
lowed by ZO-1 recruitment to the lateral surface of the cell
via a transient interaction with the 
 
a
 
-/
 
b
 
-catenin complex
(Rajasekaran et al., 1996). Indeed, it was subsequently
found that ZO-1 binds 
 
a
 
-catenin in vitro (Itoh et al., 1997),
providing the means by which ZO-1 is associated with the
catenin complex during this early stage in junction forma-
tion. As epithelial polarization proceeds, ZO-1 is sorted
out of the AJ and forms part of a separate TJ complex
(Ando-Akatsuka et al., 1999). In vitro binding experiments
have shown that ZO-2 can also bind 
 
a
 
-catenin (Itoh et al.,
1999b), indicating the possibility that ZO-2 may follow a
similar path during initial stages of junctional complex as-
sembly, either directly via interaction with 
 
a
 
-catenin or in-
directly via its association with ZO-1 (Wittchen et al.,
1999). Recent data suggest that this hierarchy of junctional
complex assembly is not absolute. Troxell et al. (2000)
have shown that TJ assembly was extensive in MDCK cells
expressing a mutant E-cadherin protein lacking the extra-
cellular domain required for cell–cell adhesion, suggesting
the possibility that TJs can assemble in the absence of an
initial E-cadherin–mediated cell adhesion event.
Here we pursue the role of ZO-3 in epithelial cell physi-
ology by expressing mutant ZO-3 constructs in MDCK
cells. Through studies on TJ assembly and the domains re-
sponsible for protein–protein interactions, we have dem-
onstrated that exogenous expression of the PDZ domain-
containing, amino-terminal half of ZO-3 perturbs both TJ
and AJ assembly. Moreover, such expression also affects
actin dynamics and the biochemical properties of at least
one adherens junction protein. Through in vitro binding
assays we show that this amino-terminal half of ZO-3 pref-
erentially binds ZO-1 and actin filaments. These studies
provide the first functional information on ZO-3 and help
 
to define how the molecular constituents of the junctional
complex may interact and assemble in epithelial cells.
 
Materials and Methods
 
Plasmid Construction and MDCK Transfections
 
The ZO-3 constructs used in this study are shown in Fig. 1. A vesicular
stomatitis virus glycoprotein (VSVG) epitope-tagged version of full-
length ZO-3 (FLZO-3) in the expression vector pBK-CMV used for trans-
fection of MDCK cells has been described (Haskins et al., 1998). The
stable cell line MDCK/FLZO-3 was generated by transfection using Lipo-
fectin (GIBCO BRL) and G418 selection as described (Haskins et al.,
1998). A construct composed of the amino-terminal half of ZO-3 (NZO-3)
contains the three PDZ domains, arginine-rich region, and proline-rich
domain (amino acids 1–454). For stable transfection in MDCK cells, this
construct was subcloned into pBK-CMV with a VSVG epitope tag in-
serted at the carboxy terminus. NZO-3 was also subcloned into the pFast-
Bac HT vector series of the Baculovirus eukaryotic expression system
(GIBCO BRL) to generate a 6-histidine–tagged protein used for in vitro
binding experiments. A construct composed of the entire carboxy-termi-
nal half of ZO-3 (CZO-3) containing the SH3 and GUK domains, fol-
lowed by the acidic region (amino acids 455–899) was subcloned into
pBK-CMV with a VSVG-epitope tag at the carboxy terminus and stably
transfected into MDCK cells. CZO-3 was also inserted into the pFastBac
HT vector series to generate a 6-histidine–tagged recombinant protein for
binding analyses. For each stable cell transfection, multiple clones were
selected and analyzed for expression of constructs by immunofluores-
cence and immunoblotting.
 
Calcium Switch and Cytochalasin D Treatment
 
For transepithelial resistance (TER) measurements and immunohis-
tochemistry, untransfected or transfected MDCK cells grown as previ-
ously described (Howarth et al., 1992) were plated on Transwell polycar-
bonate membrane filter inserts (0.4 
 
m
 
m pore size; Costar Corp.) coated
with rat tail collagen at a cell density of 3 
 
3 
 
10
 
5
 
 cells/cm
 
2
 
. Filters were fed
every day. Calcium switch experiments were performed with minor modi-
fications of previously published methods (Cereijido et al., 1978; Gum-
biner and Simons, 1986). In brief, cells were trypsinized and replated on
filters in DME containing 1.8 mM calcium for 2–3 h to allow attachment.
Filters were then rinsed 2
 
3
 
 with PBS without added calcium (PBS
 
2
 
) be-
fore switching to low calcium (5 
 
m
 
M) DME overnight (
 
z
 
15 h) to allow
disassembly of the junctional complex. Cells were then switched back to
1.8 mM calcium-containing media at 
 
t
 
 
 
5 
 
0, and junctional reassembly was
followed for various times. Control cells used for determination of steady-
state levels of NZO-3 were trypsinized, replated in normal calcium media,
and incubated for 
 
z
 
65 h.
Cytochalasin D (cD) (4 
 
m
 
g/ml) in Hepes-buffered saline plus glucose
(HBSG; 10 mM Hepes, pH 7.4, 5.4 mM KCl, 137 mM NaCl, 1.3 mM
CaCl
 
2
 
, 0.5 mM MgCl
 
2
 
, 5.6 mM glucose), was added to filter-grown mono-
layers for 60 min and then was washed out by rinsing filters 3
 
3
 
 with
HBSG. Cells were then incubated in HBSG without cD for another 2 h.
 
Transepithelial Resistance Measurements
 
TER was measured with a Millicell-ERS apparatus (Millipore) in HBSG
as previously described (Stevenson and Begg, 1994). In the results de-
picted in Fig. 3 (A and B), duplicate filters from each cell line were mea-
sured for each time point, and the experiment was performed at least
twice. Data from at least two experiments (
 
n
 
 
 
.
 
 4 filters) are presented as
mean 
 
6
 
 SEM. Data from single clones of parental, MDCK/NZO-3,
MDCK/CZO-3, and MDCK/FLZO-3 cells are shown. Two additional, in-
dependently selected MDCK/NZO-3 cell lines were tested in both the cal-
cium switch and cD experiments and showed results essentially identical
to the first MDCK/NZO-3 cell line (data not shown). For calcium switch
experiments (see Fig. 3 A), TER is plotted in ohm 
 
3
 
 cm
 
2
 
. For cD experi-
ments (see Fig. 3 B), TER is expressed as a percentage normalized to 
 
t
 
 
 
5
 
0. The steady-state TER of all cell lines examined was 50–60 ohm 
 
3
 
 cm
 
2
 
.
 
Antibodies
 
The following antibodies were used: rat anti–ZO-1 mAb R40.76 (Ander-
son et al., 1988), rabbit anti–ZO-2 polyclonal Ab R9989 (Jesaitis and
Goodenough, 1994), rabbit anti-VSVG (a gift from Dr. Carolyn Macha-
mer, Johns Hopkins University, Baltimore, MD), rabbit anti-occludin 
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(Wong and Gumbiner, 1997; a gift from Drs. Alpha Yap and Barry Gum-
biner, Memorial Sloan-Kettering Cancer Center, New York, NY), mouse
anti–E-cadherin mAb 3G8, (a gift from Dr. Warren Gallin, University of
Alberta, Edmonton, Canada), and rabbit anti–
 
b
 
-catenin (Sigma-Aldrich;
No. C2206). For detection of ZO-3 constructs, the following antibodies
were used: guinea pig anti–ZO-3 (Haskins et al., 1998) and mouse anti–ZO-3
mAB3260 (Chemicon International, Inc.), which both recognize an epitope
in the amino terminus of ZO-3 and were used to detect full-length ZO-3
and NZO-3; rabbit anti–ZO-3 polyclonal AB3220 (Chemicon Interna-
tional, Inc.) recognizes an epitope in the extreme carboxy terminus of ZO-3
and was used to detect CZO-3. HRP-conjugated goat anti–rabbit and
HRP-conjugated goat anti–mouse (Bio-Rad Laboratories), HRP-conju-
gated goat anti–guinea pig and HRP-conjugated anti–rat (Jackson Immu-
noResearch Laboratories) were used as secondary antibodies for immuno-
blots. Rhodamine-conjugated donkey anti–rabbit, rhodamine-conjugated
donkey anti–guinea pig, rhodamine-conjugated goat anti–rat, rhodamine-
conjugated goat anti–mouse, FITC-conjugated goat anti–rat, and Texas
red–conjugated goat anti–mouse (Jackson ImmunoResearch Laboratories)
were used as secondary antibodies for indirect immunofluorescence.
 
Immunohistochemistry
 
For immunofluorescence staining with anti-VSVG, cells grown on col-
lagen-coated coverslips were fixed with 5% acetic acid in ethanol for 5
min at 
 
2
 
20
 
8
 
C and permeabilized with 0.2% Triton X-100 (TX-100) in
TBS plus 1.8 mM calcium (TBS
 
1
 
) for 4 min at room temperature. For all
other staining, cells grown on filters were fixed with 2.5% paraformalde-
hyde in TBS and permeabilized with 0.2% TX-100. Rhodamine-conju-
gated phalloidin (Sigma-Aldrich) was used to stain F-actin. Coverslips and
filters were viewed on a Zeiss Axioskop (Carl Zeiss, Inc.).
 
Protein Expression Analysis and TX-100 Extraction
 
Parental or MDCK/NZO-3 cells grown on 35-mm tissue culture dishes
were subjected to a calcium switch, and total lysates were made from cells
6, 12, 24, and 48 h after the re-addition of calcium. The steady-state level
of NZO-3 was assessed on control cells not subjected to calcium switch
that were maintained in normal calcium media for 
 
z
 
65 h. Monolayers
were rinsed 2
 
3
 
 with ice-cold TBS
 
1
 
 and scraped up into 1 ml ice-cold
TBS
 
1
 
 plus protease inhibitor cocktail (1 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml chymo-
statin, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pepstatin, and 1 mM Pefabloc SC; Boeh-
ringer). Scraped cells were then harvested by centrifugation at 6,500 rpm
for 5 min at 4
 
8
 
C. Cell pellets were resuspended in hot SDS lysis buffer (10
mM Tris, pH 7.8, 1% SDS) plus protease inhibitors and boiled for 5 min,
shearing with a narrow bore pipette tip. Protein concentration was deter-
mined by BCA protein assay (Pierce Chemical Co.) and 20 
 
m
 
g total pro-
tein was loaded per lane on SDS-PAGE. For immunoblots, gels were
electrophoretically transferred to nitrocellulose, immunoblotted with cor-
responding antibodies, and proteins detected via ECL (Amersham Phar-
macia Biotech).
For separation of TX-100–soluble and –insoluble 
 
b
 
-catenin, parental
and MDCK/NZO-3 cells subjected to a calcium switch were extracted
with CSK buffer (10 mM Pipes, pH 6.8, 50 mM NaCl, 300 mM sucrose,
0.5% TX-100 plus 0.1 mg/ml DNAse, 0.1 mg RNAse, and protease inhibi-
tor cocktail; Troxell et al., 2000). In brief, cell monolayers grown on 35-
mm dishes were rinsed 2
 
3
 
 with ice-cold TBS
 
1
 
 and then extracted for 10
min on ice with 1.5 ml CSK buffer. Insoluble material was scraped from
the dish, and the extracts were centrifuged 10 min at 13,000 rpm at 4
 
8
 
C.
Supernatants contain the detergent-soluble pool of 
 
b
 
-catenin. Pellets con-
taining detergent-insoluble material were resuspended in 1.5 ml hot SDS
lysis buffer and boiled for 10 min. Protein concentration in each fraction
was determined by BCA protein assay, and samples were loaded for SDS-
PAGE and immunoblot analysis as above.
 
Recombinant Protein Expression and In Vitro
Binding Studies
 
Recombinant 6-histidine–tagged NZO-3 and CZO-3 were expressed in
Sf9 insect cells using a Baculovirus eukaryotic expression system (GIBCO
BRL) and purified according to previously published methods (Haskins et
al., 1998; Wittchen et al., 1999). Empty expression vector encoding the
6-histidine tag plus 36 nonspecific amino acids served as the negative con-
trol. Equal amounts of purified NZO-3 and CZO-3 were used in the bind-
ing experiments. [
 
35
 
S]Methionine-labeled in vitro–transcribed/translated
human ZO-1 was prepared as described (Haskins et al., 1998; Wittchen et
al., 1999). Expression of GST-occludin encoding the carboxy-terminal 150
amino acids of the cytoplasmic tail of chicken occludin (Furuse et al.,
 
1993) was described previously (Haskins et al., 1998; Wittchen et al.,
1999). GST–N-cingulin cDNA encoding the amino-terminal head region
(amino acids 1–378) of 
 
Xenopus
 
 cingulin in pGEX-4T1 (a gift from Dr.
Sandra Citi, University of Geneva, Geneva, Switzerland) was expressed
according to published methods (Cordenonsi et al., 1999).
The binding of NZO-3 and CZO-3 to actin, ZO-1, and occludin was
performed as previously described (Wittchen et al., 1999). Cingulin bind-
ing experiments used a modification of the methods of Cordenonsi et al.
(1999). In brief, GST–N-cingulin or GST alone was immobilized on glu-
tathione-Sepharose 4B beads, and equal amounts of purified NZO-3 or
CZO-3 were added. Binding buffer comprised of PBS plus 1% TX-100
and protease inhibitors. Binding was allowed to proceed overnight at 4
 
8
 
C,
followed by washing with the same buffer, and eluting bound protein by
boiling the beads in gel sample buffer. NZO-3 and CZO-3 binding was de-
tected by immunoblot, and in the case of occludin and cingulin binding ex-
periments, the amount of bound NZO-3 and CZO-3 was compared by
Coomassie blue staining of the bound fraction.
 
Results
 
The Effect of Truncated ZO-3 Constructs on Tight 
Junction Physiology
 
We first determined which region of ZO-3 encodes the in-
formation for targeting the protein to the TJ. MDCK cells
were stably transfected with the VSVG-tagged FLZO-3,
NZO-3, and CZO-3 constructs (Fig. 1). Subcellular local-
ization of the constructs was detected by indirect immuno-
fluorescence using anti-VSVG antibodies and costaining
for ZO-1 as a marker for the TJ. FLZO-3 correctly targets
to cell borders, colocalizing with the TJ marker ZO-1 (data
not shown). The NZO-3 construct also colocalizes with en-
dogenous ZO-1 at cell borders (Fig. 2); furthermore, its lo-
calization was also indistinguishable from endogenous ZO-1
as assayed by 0.2 
 
m
 
m Z-section confocal microscopy (data
not shown). The nuclear staining visible with the anti-
VSVG staining is nonspecific as the same staining pattern is
seen in untransfected parental MDCK cells (see Fig. 5 A).
Fig. 2 also shows that when expressed in MDCK cells,
CZO-3 is absent from cell borders and is instead diffusely
distributed in the cytoplasm. Expression of the CZO-3 con-
struct in these cells was confirmed by immunoblot (data
not shown). Combined, these data indicate that the infor-
mation necessary for proper targeting of ZO-3 to the TJ is
contained within the amino-terminal half of the protein.
We next examined the effect of exogenous expression of
these constructs on TJ formation using two experimental
paradigms. The first approach is based on the observation
Figure 1. Schematic diagram of the ZO-3 constructs used in this
study. Full-length ZO-3 (FLZO-3) contains three PDZ domains,
an arginine-rich basic region (1), a proline-rich region (pro), an
SH3 domain, a GUK domain, and an acidic region (2). NZO-3
comprises the amino-terminal half of ZO-3 and contains the
three PDZ domains, basic region and proline-rich region. The
CZO-3 construct corresponds to the carboxy-terminal half of
the molecule and contains the SH3, GUK, and acidic domains.
The constructs used for generating stably transfected MDCK
cells have a VSVG epitope tag at their carboxy terminus. 
The Journal of Cell Biology, Volume 151, 2000 828
 
that AJs and TJs are disrupted if epithelial cells are grown in
medium containing subphysiological calcium concentration
(5 
 
m
 
M). Subsequent restoration of physiological levels of
calcium (1.8 mM) results in the synchronous de novo assem-
bly of both junction types (Cereijido et al., 1978; Gumbiner
and Simons, 1986). Filter-grown monolayers of parental,
NZO-3, CZO-3, or FLZO-3–expressing MDCK cells were
grown overnight in low calcium media. Physiological con-
centration of calcium was added back at 
 
t
 
 
 
5 
 
0, and TJ as-
sembly was monitored by measuring TER over a 48-h time
period. As shown in Fig. 3 A, parental MDCK cells undergo
an initial rapid increase in TER to over 175 ohm 
 
3
 
 cm
 
2
 
 by
12 h. Resistance peaked at 12–24 h, before declining and lev-
eling off to 
 
z
 
50 ohm 
 
3
 
 cm
 
2
 
 by 96 h. Cell lines expressing the
CZO-3 and FLZO-3 constructs followed a similar trend,
plateauing at the same steady-state level as parental cells. In
contrast, NZO-3–expressing cells exhibited delayed TER
development, with no initial overshoot typical of the other
cell lines. However, regardless of the delay, NZO-3–express-
ing cells reached a steady-state TER similar to that of the
other cell lines by 48–96 h. The TER of all cells at 96 h is
similar to that of untreated cells (data not shown).
We corroborated the results obtained in the calcium
switch experiments by determining the effect of ZO-3 con-
struct expression on TJ reformation in MDCK cells
treated with the actin-disrupting drug cD. In cells treated
with cD, the apical actin cytoskeletal ring associated with
the junctional complex is disrupted into large punctate ag-
gregates that colocalize with similarly disrupted TJ pro-
teins ZO-1, ZO-2, ZO-3, and occludin (Stevenson and
Begg, 1994; Wittchen et al., 1999). The cD-treated cells
also show a sharp drop in TER, indicating a loss of func-
tional TJs. It was shown that this effect is reversible, and
upon washout of cD, TJs reassemble synchronously (Ma-
dara et al., 1986; Stevenson and Begg, 1994). We treated
our MDCK cell lines with cD for 60 min, and the drug was
then washed out (Fig. 3 B). Upon cD treatment all cell
 
lines exhibited an immediate and substantial decrease in
TER. After cD washout, parental, FLZO-3–, and CZO-
3–expressing cells recovered TER values equal to or
greater than 
 
t
 
 
 
5 
 
0 values within 1 h. However, NZO-
3–expressing cells showed a delayed TER recovery from
cD treatment and failed to reach 
 
t
 
 
 
5 
 
0 levels for the dura-
tion of the experiment. This result is in agreement with the
calcium switch experiment (Fig. 3 A) and demonstrates
that MDCK cells expressing the NZO-3 construct display
an impaired ability to assemble functional TJs.
 
Junctional Protein Localization
 
The physiological data suggesting impaired TJ-forming
ability in NZO-3–expressing cells prompted us to assess
the localization of proteins associated with both TJs and
AJs in the calcium switch experimental system. Parental
and MDCK/NZO-3 cells grown on filters were subjected
Figure 2. The NZO-3 construct correctly targets to the TJ; the
CZO-3 does not. MDCK cells were stably transfected with VSVG-
tagged NZO-3 (MDCK/NZO-3) or CZO-3 (MDCK/CZO-3) con-
structs. Transfected cells were costained with anti–ZO-1 and anti-
VSVG antibodies to mark the TJ and localize the constructs by
indirect immunofluorescence. NZO-3 precisely colocalizes with
ZO-1 at cell borders, with additional staining visible in the cyto-
plasm. CZO-3 is found mainly in the cytoplasm and is absent from
cell borders. The nuclear staining in the MDCK/NZO-3 cells
stained with anti-VSVG is nonspecific (see Fig. 5). Bar, 15 mm.
Figure 3. Expression of NZO-3 delays TJ formation. (A) NZO-3
expression in MDCK cells subjected to a calcium switch delays re-
establishment of TER. Filter-grown confluent monolayers of un-
transfected parental cells or MDCK cell lines stably expressing
NZO-3, CZO-3, or FLZO-3 were incubated in calcium-free media
for z15 h to disrupt intercellular junctions and then switched to me-
dia containing 1.8 mM calcium at t 5 0 to induce synchronous as-
sembly of intercellular junctions. TER was measured over 96 h after
calcium switch. CZO-3 and FLZO-3 expressing cell lines show TER
recovery dynamics similar to parental cells. NZO-3–expressing cells
display a delay in TER recovery, but reach the same TER as the
other cell lines by 48–96 h. (B) Expression of NZO-3 delays TER
recovery in MDCK cells after cD treatment. cD was added to filter-
grown confluent monolayers at t 5 0 and then washed out after 60
min. TER measurements were taken every 30 min to monitor TJ
breakdown and reformation. TER for each cell line is expressed as
percentages of the values at t 5 0. After 60 min of cD treatment, all
cell lines exhibit a significant drop in TER. After cD washout,
MDCK/CZO-3, MDCK/FLZO-3 and parental cells recover TER
to values greater than t 5 0, whereas MDCK/NZO-3 cells do not
fully recover TER in the duration of the experiment. 
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to a calcium switch and protein localization was deter-
mined 6, 12, 24, and 48 h after re-addition of calcium. As
shown in Fig. 4 A, ZO-1 is localized at cell–cell contacts
within 6 h after re-addition of calcium. In the 12–48-h time
period, the parental cells develop the cobblestone unifor-
mity of shape and size that is typical of an MDCK epithe-
lial cell monolayer at steady-state. The appearance of ZO-1
at cellular contacts 6 h after re-addition of calcium corre-
lates well with the rapid increase in TER observed in the
parental cells (Fig. 3 A). In contrast, cells expressing
NZO-3 showed a significant delay in ZO-1 recruitment to
cell borders after re-addition of calcium (Fig. 4 A). At 6 h,
only small, isolated clusters of cells showed ZO-1 staining
at cell borders. Over time the areas of cell monolayer that
show ZO-1 localization at cell–cell contacts increase in
size. At 6, 12, and 24 h when ZO-1 is not yet fully localized
to cell borders, ZO-1 also localizes to large intracellular
aggregates and linear planes of contact between neighbor-
ing cells. Complete localization of ZO-1 at the junctional
membrane in NZO-3–expressing cells did not occur until
48 h after re-addition of calcium. ZO-1 localization in both
cell types at 48 h is indistinguishable from untreated,
steady-state cells (data not shown). Both parental and
MDCK/NZO-3 cells displayed no detectable differences
in expression levels of ZO-1 (or any other junctional pro-
tein examined; see Fig. 9 immunoblot) at 6, 12, 24, and
48 h. The delayed targeting of the TJ protein ZO-1 in
MDCK/NZO-3 cells correlates with the delay in TER re-
covery after calcium switch (Fig. 3 A). The localization of
the TJ proteins ZO-2, endogenous ZO-3, and the integral
membrane protein occludin was identical to that of ZO-1
in the MDCK/NZO-3 cells (data not shown).
To rule out the possibility that the isolated islands of
MDCK/NZO-3 cells showing ZO-1 staining encircling cell
peripheries at 6 h arose from cell clusters that did not dis-
assemble their TJs during incubation in low calcium, and to
demonstrate that the recruitment of ZO-1 to cell peripher-
ies occurred de novo, we looked at ZO-1 localization in
MDCK/NZO-3 cells before the re-addition of calcium (
 
t
 
 
 
5
 
0). As viewed by phase-contrast microscopy, cells plated at
an identical density on glass coverslips show a confluent
distribution at 
 
t
 
 
 
5 
 
0, although the cells are somewhat re-
tracted from each other due to the dissociation of adherens
and TJs in low calcium (Fig. 4 B). ZO-1 staining is com-
pletely disrupted, and is present only in large intracellular
aggregates and thick, linear planes of contact between
neighboring cells. No cells show ZO-1 staining encircling
their peripheries at 
 
t
 
 
 
5 
 
0. Thus, ZO-1 (and ZO-2, endoge-
nous ZO-3, and occludin; data not shown) is recruited
from an intracellular location to cell–cell contacts upon re-
addition of calcium, and this recruitment process is delayed
in NZO-3–expressing MDCK cells.
The disrupted localization of TJ proteins during junc-
tional assembly after calcium switch in cells expressing
NZO-3 indicates that this construct interferes with the for-
mation of the complex of proteins found at the TJ. We
therefore examined the localization of the construct itself
during this process. The anti-VSVG antibody only weakly
recognizes its epitope on NZO-3 in immunofluorescence
and was not visible in filter-grown cells. Hence, MDCK/
NZO-3 cells grown on coverslips and subjected to a cal-
cium switch were costained with the anti–ZO-1 and anti-
VSVG (NZO-3) antibodies. Parental MDCK cells stained
with anti-VSVG serve as a negative control and show that
this antibody exhibits nonspecific nuclear staining in un-
transfected cells (Fig. 5 A). At the earliest time points (6,
12, and 24 h), the NZO-3 construct appears at only those
cell borders that also show ZO-1 localization. MDCK/
NZO-3 cells stained with anti-VSVG antibody also exhibit
a faint, granular cytoplasmic staining above background.
NZO-3 staining is only faintly visible at 48 h, likely due to
the lower levels of construct expression at this time point
(see Fig. 9 immunoblot). In areas where NZO-3 is visible,
it was colocalized with ZO-1 at all cell–cell contacts. Inter-
estingly, NZO-3 was absent from the intracellular aggre-
gates and linear planes of ZO-1 staining observed at early
time points, and was only colocalized with ZO-1 at points
of cell–cell contact formed by mature TJs (Fig. 5 B).
The actin cytoskeleton is an important structural and a
functional element of the TJ (Hirokawa and Tilney, 1982;
Madara, 1987). Actin filaments have been shown to inter-
act directly with multiple TJ proteins (Itoh et al., 1997;
Figure 4. NZO-3 expression alters the
distribution of ZO-1 during the early
stages of TJ assembly. (A) Parental
MDCK (P) and MDCK/NZO-3 (NZO-
3) cells were subjected to a calcium
switch, and the localization of ZO-1 at 6,
12, 24, and 48 h after the re-addition of
calcium was determined by immunofluo-
rescence with anti–ZO-1 antibody. In
parental cells, ZO-1 is completely local-
ized to cell borders after 6 h in calcium-
containing media. Over 48 h the cells be-
come more tightly packed and uniform
in size. In NZO-3 expressing cells, only
scattered islands of cells showed ZO-1 localization at cell borders by 6 h. The num-
ber of cells with ZO-1 localized to cell–cell contact sites increases over time and is
complete by 48 h after re-addition of calcium. (B) No MDCK/NZO-3 cells show
ZO-1 localization around their peripheries at t 5 0 in the calcium switch. Phase-con-
trast image shows that cells form a confluent monolayer at t 5 0 of calcium switch.
Anti–ZO-1 immunofluorescence shows ZO-1 staining in large intracellular aggre-
gates and in thick bars at sites where two cells make contact. Bars: (A and B) 30 mm. 
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Fanning et al., 1998; Wittchen et al., 1999). Disruption of
the actin cytoskeleton is associated with impaired barrier
function of the TJ (Madara et al., 1986; Madara and Pap-
penheimer, 1987; Stevenson and Begg, 1994), whereas the
fence function appears to be unaffected (Takakuwa et al.,
2000). Actin localization during TJ assembly in the cal-
cium switch system was studied by rhodamine-phalloidin
staining of actin filaments (Fig. 6). In parental MDCK
cells, actin recruitment to a ring-like structure at the apical
aspect of the lateral cell surface occurs rapidly after re-
addition of calcium; as early as 6 h all parental cells show a
circumferential actin ring. This ring thickens and con-
denses as the cells become more tightly packed and uni-
form in size in the 12–48-h time period. However, exoge-
nous expression of NZO-3 delays recruitment of actin to
the apical ring in a manner similar to that observed with
ZO-1. Development of an apical actin ring at points of
cell–cell contact in MDCK/NZO-3 cells occurred only in
isolated patches of cells at 6 h, with the final localization
not complete until 48 h. In addition, at the earlier time
points (6, 12, and 24 h), actin also localized to large aggre-
gates in cells which show underdeveloped actin rings. The
delayed association of actin filaments with the junctional
complex in MDCK/NZO-3 cells is likely a factor in the de-
layed TJ barrier formation in these cells.
As the prevalent model of TJ formation involves coordi-
nated assembly with the AJ, we were interested to deter-
mine if E-cadherin was delayed in its movement to the junc-
tional complex in MDCK/NZO-3 cells in a calcium switch.
In parental cells, E-cadherin appears at all cell–cell contacts
6 h after re-addition of calcium (Fig. 7). This time course of
E-cadherin recruitment to the AJ mirrors that of TJ assem-
 
bly and recruitment of ZO-1 to the TJ (Fig. 4 A). Similar to
ZO-1, E-cadherin localization during the calcium switch
was also delayed in NZO-3–expressing cells (Fig. 7). At 6 h,
E-cadherin is localized to cell–cell contacts in small, isolated
clusters of cells; these cell clusters also show ZO-1 localiza-
tion to the junctional complex. An increasing number of
cells show junctional E-cadherin staining at 12 and 24 h, but
it is not until 48 h after calcium re-addition that E-cadherin
is completely recruited to all cell borders in MDCK/NZO-3
cells. In addition, we identified cells where junctional re-
cruitment of E-cadherin precedes that of ZO-1. The disrup-
tion of E-cadherin localization in MDCK/NZO-3 cells after
calcium switch indicates that adherens and TJs are both af-
fected by exogenous expression of the NZO-3 construct.
We corroborated our E-cadherin findings by assessing the
localization of 
 
b
 
-catenin, an AJ protein peripherally associ-
ated with the membrane (Fig. 8). In parental cells, 
 
b
 
-catenin
appears at cell–cell contacts 6 h after calcium re-addition in
a manner identical to the localization of E-cadherin after
calcium switch (data not shown). However, in a distribution
similar to E-cadherin and ZO-1, 
 
b
 
-catenin recruitment to
the lateral cell surface during junctional complex assembly
was delayed in MDCK/NZO-3 cells.
 
Protein Biochemistry
 
In addition to the altered localization of junctional com-
plex proteins and disruption of the actin cytoskeleton, it
is possible that the perturbation of junctional assembly in
NZO-3–expressing cells is also due to changes in the
expression levels of component proteins. Equivalent pro-
tein loadings of whole cell lysates harvested from paren-
tal and MDCK/NZO-3 cells at 6, 12, 24, and 48 h after re-
Figure 5. NZO-3 colocalizes
with ZO-1 around cell bor-
ders during TJ assembly af-
ter calcium switch. (A) Pa-
rental MDCK (P) and
MDCK/NZO-3 (NZO-3)
cells were subjected to a calcium switch and then costained with anti–ZO-1 and anti-VSVG (NZO-
3) antibodies at 6, 12, 24, and 48 h after the re-addition of calcium. Parental MDCK cells stained
with anti-VSVG antibodies show nonspecific nuclear staining. In MDCK/NZO-3 cells, NZO-3 is
present at cell borders of small groups of cells where it colocalizes with ZO-1. These groups of cells
showing NZO-3 and ZO-1 around their peripheries enlarge over time, with complete localization
at cell borders by 48 h. Boxed areas are enlarged in B. (B) NZO-3 colocalizes with ZO-1 along ex-
tended cell peripheries, but not in intracellular aggregates or initial planes of cell–cell contact.
Shown is a cell with mature TJ staining (asterisk) where ZO-1 and NZO-3 colocalize. However,
NZO-3 does not colocalize with ZO-1 at initial cell–cell contact planes (arrow) or in large intracel-
lular aggregates (arrowheads). Bars: (A) 30 mm; (B) 10 mm. 
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addition of calcium were immunoblotted for the NZO-3
construct, endogenous ZO-3, ZO-1, ZO-2, occludin, and
E-cadherin (Fig. 9 A). As expected, no NZO-3 was de-
tected in untransfected parental cells. NZO-3 expression
in MDCK/NZO-3 cells increased in response to the cal-
cium jump, with highest expression at 6 h. Construct ex-
pression then gradually decreased over time and re-
turned to stable, steady-state levels. This decrease over
time correlates well with recovery of TER and the nor-
mal localizations of junctional proteins over the same
time period. The expression levels of all other proteins
examined did not change over the course of the calcium
switch in either parental or MDCK/NZO-3 cells. There
was also no detectable difference in the expression levels
between parental and MDCK/NZO-3 cells at any of the
time points, indicating that the effects on junctional as-
sembly caused by NZO-3 expression were not due to al-
tered expression of other junctional proteins. We ob-
served a shift in mobility of occludin in both parental and
MDCK/NZO-3 cells to a higher molecular weight species
over time, corresponding to an increase in phosphoryla-
tion of this protein as the TJ assembles, as previously de-
scribed (Sakakibara et al., 1997).
In epithelial cells, 
 
b
 
-catenin is found in two distinct
pools: a TX-100–insoluble pool, which comprises the
 
b
 
-catenin molecules which are bound to E-cadherin and
linked to the actin cytoskeleton via 
 
a
 
-catenin, and a TX-
100–soluble pool that represents the non–AJ-associated,
cytoplasmic pool of free 
 
b
 
-catenin (Fagotto et al., 1996;
Funayama et al., 1995). Because these TX-100–soluble and
–insoluble pools of b-catenin are functionally distinct, we
examined the expression levels of b-catenin in equivalent
protein loadings of TX-100–extracted parental and NZO-
3–expressing cells. Fig. 9 B shows that at 12 and 24 h after
re-addition of calcium there is more soluble b-catenin in
MDCK/NZO-3 cells relative to parental cells. This differ-
ence is present but less pronounced at 48 h. Equivalent
samples of the TX-100–insoluble fractions of parental and
MDCK/NZO-3 cells show no difference in b-catenin lev-
els. No differences were observed in the amount of a-cate-
nin in the soluble or insoluble pools of TX-100–extracted
parental or MDCK/NZO-3 cells (data not shown).
Protein Binding Analyses
We determined which of the known protein–protein inter-
actions of ZO-3 could be mapped to the amino- and car-
boxy-terminal halves of the molecule. It has been previ-
ously shown that ZO-3 binds directly to actin filaments in
vitro (Wittchen et al., 1999). In addition, ZO-3 also binds
ZO-1, occludin, and the amino terminus of cingulin, but
not to ZO-2 (Haskins et al., 1998; Cordenonsi et al., 1999).
Fig. 10 A shows Coomassie-stained samples of the purified
NZO-3 and CZO-3 proteins, demonstrating the equal
amounts of these proteins used in subsequent binding ex-
periments. As shown by actin cosedimentation assays in
Fig. 10 B, substantial NZO-3 is found in the pellet in the
presence of F-actin whereas a much smaller amount is visi-
ble in the pellet in the absence of actin, likely due to a low
level of fusion protein aggregation. CZO-3 remained in
the supernatant fraction in both the presence and absence
of actin filaments. Therefore, the actin binding site(s) of
ZO-3 reside in the amino terminus of the protein. To map
the binding site(s) of ZO-1 on ZO-3, we performed a bind-
ing assay using 35S-labeled in vitro–transcribed/translated
human ZO-1 added to NZO-3 or CZO-3 affinity columns.
As shown in Fig. 10 C, NZO-3 retains ZO-1, whereas
CZO-3 and the negative control do not. This demonstrates
that the amino-terminal half of ZO-3 is responsible for
binding to ZO-1. This is consistent with previous studies
Figure 6. NZO-3 expression disrupts actin filament organization during early stages of junction as-
sembly. (A) Parental MDCK (P) and MDCK/NZO-3 (NZO-3) cells were subjected to a calcium
switch. Actin filaments were visualized with rhodamine-phalloidin at 6, 12, 24, and 48 h after the
re-addition of calcium. In parental cells, actin is concentrated in an apical circumferential ring at
the junctional complex in all cells after 6 h in normal calcium. MDCK/NZO-3 cells show actin
staining present in large aggregates at early time points (6, 12, and 24 h), with small clusters of
cells containing a prominent apical actin ring, similar to the observations with ZO-1 and NZO-3
(Figs. 4 and 5). Actin is not localized to the apical circumferential ring in all cells until 48 h after
calcium re-addition. Boxed areas of 12 h images are enlarged in B. (B) In MDCK/NZO-3 (NZO-
3) cells at 12 h, F-actin aggregates (arrow) are seen in cells which have not fully developed an api-
cal actin ring. At the same time point, parental cells (P) have conspicuous apical actin rings and in-
tracellular aggregates are absent. Bars: (A) 30 mm; (B) 15 mm.The Journal of Cell Biology, Volume 151, 2000 832
showing that ZO-1 and ZO-2 bind each other via their sec-
ond PDZ domains (Fanning et al., 1998; Itoh et al., 1999b).
To define the occludin binding site on ZO-3, in vitro bind-
ing assays were performed using NZO-3 and CZO-3
added to affinity columns containing immobilized GST-
occludin or GST alone, and bound proteins were detected
by immunoblot (Fig. 10 D). Both NZO-3 and CZO-3 were
specifically retained on the occludin column. Although the
NZO-3 immunoblot reaction is stronger than that for
CZO-3, the amounts of NZO-3 and CZO-3 bound to oc-
cludin appear approximately equivalent, as assayed by
Coomassie blue staining of the bound fractions. This indi-
cates that occludin binding domains of approximately
equal affinity are found in both the amino- and carboxy-
terminal halves of ZO-3. It has recently been reported that
the amino-terminal head and to a lesser degree, the car-
boxy-terminal tail of cingulin bind to full-length ZO-3 in
vitro (Cordenonsi et al., 1999). Here we determined which
half of ZO-3 binds the amino-terminal portion of cingulin.
Equivalent amounts of NZO-3 or CZO-3 were added to
GST-cingulin or GST affinity columns. As shown in Fig.
10 E, both NZO-3 and CZO-3 are specifically retained by
cingulin. Coomassie blue staining of the bound fractions
revealed no significant difference between the amounts of
NZO-3 or CZO-3 binding to cingulin, indicating that both
halves of ZO-3 bind the head region of cingulin with ap-
proximately equal affinity. In summary, the binding stud-
ies shown in Fig. 10 reveal that while both halves of ZO-3
bind to occludin and cingulin equally well, F-actin and
ZO-1 bind preferentially to NZO-3.
Discussion
In this study we have shown that exogenous expression of
the amino-terminal half of ZO-3 delays assembly of both
TJs and AJs. Analysis of protein expression showed that
whereas the overall levels of the junctional proteins ZO-1,
ZO-2, ZO-3, occludin, and E-cadherin remain constant
during 48 h of junction assembly, NZO-3 expression in-
creases in response to the calcium switch and then returns
to stable, steady-state levels over the same time period.
This return of NZO-3 expression to steady-state levels is
concomitant with recovery of TER and localization of
junctional proteins and actin to the membrane. The
amount of b-catenin in the TX-100–soluble pool is also el-
evated in NZO-3 expressing cells. Finally, in vitro binding
Figure 7. NZO-3 expression de-
lays recruitment of E-cadherin
to cell–cell contacts. Parental
(P) and MDCK/NZO-3 (NZO-
3) cells were subjected to a cal-
cium switch, and E-cadherin
and ZO-1 localization was mon-
itored by costaining at 6, 12, 24,
and 48 h after the re-addition
of calcium. In parental cells,
E-cadherin is localized to cell
borders by 6 h. By 48 h, cell
monolayers have an organized
morphology. NZO-3–express-
ing cells costained with anti–
ZO-1 and anti–E-cadherin
antibodies show a delayed
E-cadherin recruitment to cell
borders. The clusters of cells
that show E-cadherin localization at cell peripheries at early time points coincide with cells showing a similar distribution of ZO-1.
Some cells (arrow) show E-cadherin at cell borders preceding ZO-1. E-cadherin staining at cell borders is complete by 24 h after the
readdition of calcium, whereas ZO-1 staining at cell peripheries is not complete until 48 h. Bar, 30 mm.
Figure 8. NZO-3 expression
delays recruitment of b-cate-
nin to cell–cell contacts.
b-Catenin and ZO-1 local-
ization in MDCK/NZO-3
cells was monitored at 6, 12,
24, and 48 h after the re-
addition of calcium in a cal-
cium switch experiment.
NZO-3–expressing cells show
a delayed b-catenin recruit-
ment to intercellular junc-
tions, which parallels the de-
lay of E-cadherin recruitment (Fig. 7). The cells that show b-catenin localization at cell peripheries at early time points coincide with
cells showing similar distribution of ZO-1, although many cells show b-catenin at cell borders preceding ZO-1. b-Catenin staining at
cell borders is not complete until 24 h after the re-addition of calcium in MDCK/NZO-3 cells. Bar, 30 mm.Wittchen et al. Delayed Junctional Complex Assembly 833
Figure 9. Expression levels of TJ and AJ proteins during a cal-
cium switch experiment. (A) Equivalent protein loadings of
whole cell lysates of parental (P) and MDCK/NZO-3 (NZO-3)
cells were analyzed by immunoblot at 6, 12, 24, and 48 h after the
re-addition of calcium. The monoclonal antibody against ZO-3
was used to detect both the NZO-3 construct and endogenous
ZO-3; the proteins were distinguished by their difference in mo-
lecular mass. NZO-3 is not detected in parental cells. NZO-3 ex-
pression in MDCK/NZO-3 cells increases in response to the cal-
cium switch and then over time returns to stable, steady-state
levels (S). Endogenous ZO-3, ZO-1, ZO-2, occludin, and E-cad-
herin levels are unchanged during the course of the calcium
switch experiment in both cell lines, and no significant differ-
ences in these protein levels are detected between parental and
MDCK/NZO-3 cells at any time points. Occludin shows a shift to
a higher molecular weight species in both cell lines over time. (B)
MDCK/NZO-3 cells have more soluble b-catenin than parental
cells. At indicated time points after a calcium switch, parental (P)
and MDCK/NZO-3 (N) cells were extracted with CSK buffer
(see Materials and Methods) to separate TX-100–soluble and
–insoluble pools of b-catenin. Samples containing equal amounts
of total cellular protein were analyzed for b-catenin expression
by immunoblot. The amount of soluble b-catenin is greater in
MDCK/NZO-3 cells than parental cells at 12 and 24 h, and to a
lesser degree at 48 h after the re-addition of calcium. There is no
detectable difference in the amount of insoluble b-catenin be-
tween parental and MDCK/NZO-3 cells.
Figure 10. In vitro binding analyses show that NZO-3 binds F-actin
and ZO-1 exclusively; both NZO-3 and CZO-3 bind occludin and
cingulin. (A) Coomassie blue–stained gel showing the equivalent
amounts of NZO-3 (N) and CZO-3 (C) fusion proteins used in all
subsequent binding assays. (B) NZO-3 specifically cosediments
with actin filaments; CZO-3 does not. Equivalent amounts of
NZO-3 or CZO-3 were centrifuged in the presence (1) or absence
(2) of F-actin. Stoichiometrically equivalent aliquots of superna-
tants (S) and pellets (P) were analyzed by immunoblot. NZO-3,
but not CZO-3, is found in the F-actin pellet. (C) NZO-3 binds
ZO-1; CZO-3 does not. 35S-labeled in vitro–transcribed/translated
ZO-1 was incubated with affinity resin containing equal amounts
of NZO-3 or CZO-3. The 6-histidine tag plus 36 nonspecific amino
acids served as negative control (2). As detected by autoradio-
gram, ZO-1 is retained by the NZO-3-containing resin and does
not bind to CZO-3 or the negative control peptide. (D) Both
halves of ZO-3 bind occludin with similar affinity. NZO-3 and
CZO-3 were incubated with affinity resin containing immobilized
GST-occludin (1), or GST alone (2). Bound protein was eluted
with glutathione and analyzed by immunoblot with anti–ZO-3 an-
tibodies (first four lanes) or Coomassie blue staining (last two
lanes). Both NZO-3 and CZO-3 are retained by GST-occludin and
not by GST alone. The Coomassie blue–stained lanes show that
approximately equal amounts of NZO-3 and CZO-3 (arrows) are
bound. (E) Both halves of ZO-3 bind to the amino-terminal head
region of cingulin. NZO-3 or CZO-3 were added to an affinity col-
umn containing the amino-terminal head region of cingulin (N-
cing) fused to GST (1) or GST alone (2). Bound fractions were
immunoblotted with antibodies specifically recognizing NZO-3 or
CZO-3 (first four lanes) or stained with Coomassie blue (last two
lanes). Both NZO-3 and CZO-3 are retained on the GST–N-cingu-
lin column but not on GST alone. Coomassie blue staining of the
bound fractions shows approximately equal amounts of NZO-3 or
CZO-3 (arrows) are bound. The other protein bands visible in the
Coomassie blue–stained samples correspond to GST–N-cingulin.The Journal of Cell Biology, Volume 151, 2000 834
experiments revealed that the PDZ domain-containing
amino-terminal half of ZO-3 binds to ZO-1 and F-actin,
whereas both halves of ZO-3 appear to bind occludin and
cingulin. These results suggest that a mechanism involving
assembly of the actin cytoskeleton at the junctional mem-
brane mediated through ZO-3 and/or ZO-1 underlies the
inhibition of junctional assembly by NZO-3.
The amino-terminal half of ZO-3 contains three PDZ
domains, an arginine-rich domain and a proline-rich re-
gion. This portion of the molecule correctly localizes to the
TJ, whereas the carboxy-terminal half, which contains the
SH3 domain, GUK domain, and acidic region, remains dif-
fusely distributed in the cytoplasm. This is in contrast to
the findings for ZO-1, where it was shown that the region
encompassing the GUK and acidic region is required for
correct targeting (Fanning et al., 1998). Furthermore,
when just the three PDZ domains of ZO-1 were expressed
in MDCK cells, this construct failed to localize to the TJ
(Reichert et al., 2000) and induced an epithelial to mesen-
chymal transition. Our results indicate that the PDZ do-
main-containing region of ZO-3 contains functional char-
acteristics distinct from those of ZO-1.
Physiological data pertaining to the formation of the TJ
barrier during junction assembly was obtained by using
TER as an indicator of TJ integrity. Exogenous expression
of NZO-3, CZO-3, or FLZO-3 did not alter steady-state
TER levels (data not shown). However, when TER was
measured during the time course of de novo TJ assembly
in the calcium switch experimental system, it became ap-
parent that expression of NZO-3 exerted a dominant-
negative effect. Whereas CZO-3 or FLZO-3 expression
did not affect TER recovery after calcium switch com-
pared with untransfected parental MDCK cells, a calcium
switch–induced increase in NZO-3 expression caused a
significant lag in TER recovery after the re-addition of cal-
cium (Fig. 3 A). It was not until 48 h that MDCK/NZO-3
cells approached the TER levels of the other cell lines, an
effect that temporally correlated with the return of NZO-3
expression to steady-state levels. The fact that steady-state
TER levels were not affected by steady-state NZO-3 ex-
pression indicates that this construct exerts its effect only
at the higher expression levels induced by the calcium
switch and/or specifically during the assembly process, al-
though it can not be ruled out that other undetected phe-
notypic alterations may be occurring.
We used recovery from cD treatment as a second TJ as-
sembly paradigm, and these experiments corroborated the
calcium switch results. When parental cells or cell lines ex-
pressing FLZO-3, NZO-3, or CZO-3 were treated with the
actin-disrupting drug, all showed the expected immediate
drops in TER. However, when cD was washed out, the
MDCK/NZO-3 cells displayed a lag in TER recovery (Fig.
3 B). These results are consistent with the hypothesis that
the NZO-3 construct exerts its effects on junction assem-
bly through interactions with the actin cytoskeleton.
An unexpected result of NZO-3 expression during the
calcium switch experiment was that AJ formation, as as-
sessed by localization of E-cadherin (Fig. 7) and b-catenin
(Fig. 8) to cell borders, was also delayed. The current
model of junctional complex assembly in polarized epithe-
lial cells is based on the discovery that E-cadherin–medi-
ated cell adhesion provides the initial step that must occur
before TJs can form (Gumbiner et al., 1988). Our data
support the novel concept that exogenous expression of a
truncated TJ protein component can exert effects on the
AJ-associated proteins E-cadherin and b-catenin. The fact
that both TJ and AJ proteins are similarly delayed in their
assembly at the membrane lends credence to the notion
that the two types of junctions share a coordinated assem-
bly process, and that NZO-3 affects one or more steps in
this process.
Immunofluorescence localization experiments showed
that the TJ proteins ZO-1, ZO-2, endogenous ZO-3, and
occludin, and the AJ proteins E-cadherin and b-catenin
were mislocalized during the early stages of junction as-
sembly after calcium switch (Figs. 4, 7, 8, and data not
shown). Moreover, the recovery of the typical localization
of these proteins at cell borders temporally correlated with
TER recovery after calcium switch. The fact that at later
time points the cells were able to overcome the inhibitory
effect exerted by NZO-3, as determined by the recovery of
TER and correct targeting of ZO-1, ZO-2, ZO-3, occludin,
E-cadherin and b-catenin to cell–cell contacts, is likely due
to the observed return of NZO-3 protein expression to
steady-state levels at later time points (Fig. 9 A). The
mechanism(s) by which the calcium switch treatment
causes NZO-3 expression to increase and then return to
stable, steady-state levels is not known, although the effect
was observed in repeated experiments with the same cell
line (data not shown). Regardless, our results demonstrate
that the NZO-3 construct has a dominant-negative effect
on junctional complex assembly.
Immunofluorescence staining of the NZO-3 construct
was faint at the later time points, likely due to the lower
levels of NZO-3 expression. We did not try to boost ex-
pression levels with sodium butyrate because such treat-
ment was toxic to the cells after periods longer than over-
night, and overnight pulses of sodium butyrate treatment
during calcium switch caused TER levels in parental cells
to fluctuate significantly (data not shown). In addition,
the anti-VSVG antibody only weakly reacted with our
epitope-tagged construct in immunofluorescence and ex-
hibited nonspecific nuclear staining, making it difficult to
interpret the finer details of NZO-3 localization. However,
we were able to determine that NZO-3 colocalizes with
ZO-1 at cell borders at more mature TJs during calcium
switch (Fig. 5). The NZO-3 construct did not colocalize
with ZO-1 in the large intracellular aggregates that were
observed in cells lacking cell border staining or with thick
bars of ZO-1 at single cell–cell contacts that may represent
two adjacent cells beginning TJ formation (Fig. 5). Be-
cause of the high nonspecific background staining, it is dif-
ficult to see whether another pool of NZO-3 exists in the
cytoplasm. Based on the data presented here, and by con-
focal Z-section analysis which shows precise colocalization
of NZO-3 and ZO-1 at the TJ and no overlap of NZO-3
with E-cadherin more basally situated along the lateral
membrane (data not shown), we believe the NZO-3 con-
struct is not found at the AJ in the calcium switch.
The involvement of the actin cytoskeleton in maintain-
ing TJ integrity and regulating permeability has been well
documented; this involvement is underscored by the fact
that actin has multiple protein binding partners at the TJ
(Itoh et al., 1997; Fanning et al., 1998; Wittchen et al.,
1999), which themselves interact in various ways. It can be
envisioned that this molecular architecture provides theWittchen et al. Delayed Junctional Complex Assembly 835
means by which an actin filament network can be re-
cruited to and organized in a functionally relevant manner
at the TJ. The actin cytoskeleton is also a major structural
and functional element of the AJ (Farquhar and Palade,
1963; Rimm et al., 1995; Yonemura et al., 1995), and is
present in a bundled actin belt around the apical periphery
cell at the level of the AJ. Interestingly, in MDCK/NZO-3
cells, there is a delay in actin recruitment and formation of
this perijunctional apical actin ring (Fig. 6). Because the
amino-terminal half of ZO-3 is responsible for binding
F-actin, this may represent one mechanism whereby ex-
pression of this construct affects TJ and AJ assembly.
Not only did expression of the amino terminus of ZO-3
alter the distribution of b-catenin, but there was also an in-
crease in the TX-100–soluble pool of signaling-active
b-catenin. Presumably the presence of an increased level
of the NZO-3 construct at early time points after calcium
switch results in a downstream alteration of the E-cad-
herin/catenins complex at the adherens junction, releasing
b-catenin from a cytoskeletal linkage into the TX-100–sol-
uble pool. A corresponding change in the levels of b-cate-
nin in the insoluble pool is not observed, although any
possible change may be masked by the overall high levels
of b-catenin present in these samples. Normally cytoplas-
mic b-catenin levels are strictly regulated via a ubiquitin-
mediated proteolysis pathway requiring b-catenin interac-
tion with the cytoplasmic tumor suppressor APC (Aberle
et al., 1997). Soluble b-catenin that escapes this targeted
proteolysis is capable of translocating to the nucleus where
it acts as a transcriptional transactivator in a complex with
TCF/LEF family of transcription factors to direct tran-
scription of a variety of genes that promote a proliferative
phenotype (Behrens et al., 1996; Huber et al., 1996; Tetsu
and McCormick, 1999). Recently, Stewart et al. (2000),
showed that expression of a mutant signaling-active (solu-
ble) form of b-catenin in MDCK cells caused a delay in
the establishment of tight confluent cell monolayers com-
pared with control cells, and the cells appeared more mo-
tile and formed less compact colonies when plated at a low
density. These results, taken together with our data show-
ing that NZO-3 expression delays TER formation after a
calcium switch and results in an increased level of signal-
ing-active, soluble b-catenin in these cells, suggests that
NZO-3 might act through b-catenin to exert its effects on
epithelial junctional complex formation. At present we do
not know if this action is direct or indirect.
In summary, through these studies we attempted to fur-
ther elucidate the role of ZO-3 in epithelial cell physi-
ology, including the role it plays in junctional complex
assembly and its protein binding interactions. Exoge-
nous expression of partial constructs is the experimental
method we chose to approach the dissection of ZO-3 pro-
tein function and TJ physiology. This study demonstrates
that exogenous expression of the PDZ domain-containing
amino-terminal half of ZO-3 perturbs both TJ and AJ as-
sembly. Moreover, expression of NZO-3 alters actin dy-
namics and increases the amount of soluble signaling-
active b-catenin. We are currently testing the hypothesis
that NZO-3 exerts its effect on junctional assembly via a
mechanism that involves its F-actin and ZO-1 binding abil-
ity and/or the increase in soluble b-catenin.
This paper is dedicated to the memory of Bernie Gilula. His contributions
to both our understanding of the tight junction and the career of B.R.
Stevenson were considerable. Cell biology has lost a friend.
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